Back to company

Selma Diagnostics ApS: Financial statements 2024

CVR: 36961376

Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,362,633 and a net result of DKK -2,178,400 compared with DKK -1,926,683 the year before. Equity amounted to DKK -8,094,015. The company had 2 employees in the financial year.

Gross Profit
-1,362,633 kr.
Profit/Loss
-2,178,400 kr.
Equity
-8,094,015 kr.
Total Assets
998,047 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--1.4 mio.-2.2 mio.-8.1 mio.2
2023--1.4 mio.-1.9 mio.-5.9 mio.2
2022--1.6 mio.-2.8 mio.-4 mio.2
2021--1.8 mio.-2 mio.-1.2 mio.2
2020--1.6 mio.-2.4 mio.733 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Selma Diagnostics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Selma Diagnostics ApS: The 2023 annual report is outJul 1, 2024

Selma Diagnostics ApS has published its annual report for 2023. Gross profit came to DKK -1,428,041, and the net result was DKK -1,926,683.

About Selma Diagnostics ApS

Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity amounted to DKK -11,154,823.